Fifth Third Bancorp Arrowhead Pharmaceuticals, Inc. Transaction History

Fifth Third Bancorp

$25.9 Billion
Q1 2025

A detailed history of Fifth Third Bancorp transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 471 shares of ARWR stock, worth $6,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares

471

Previous 1,370 65.62%

Holding current value

$6,240

Previous $25,000 76.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	SELL	$12.74 - $21.53 $11,453 - $19,355	-899 Reduced 65.62%	471 $6,000
Q4 2024 Jan 21, 2025	BUY	$17.7 - $26.34 $938 - $1,396	53 Added 4.02%	1,370 $25,000
Q3 2024 Oct 17, 2024	BUY	$19.36 - $29.54 $2,536 - $3,869	131 Added 11.05%	1,317 $25,000
Q2 2024 Jul 22, 2024	BUY	$21.87 - $28.24 $7,741 - $9,996	354 Added 42.55%	1,186 $30,000
Q1 2024 Apr 23, 2024	SELL	$27.21 - $39.48 $8,979 - $13,028	-330 Reduced 28.4%	832 $23,000
Q4 2023 Jan 19, 2024	BUY	$21.2 - $31.03 $3,688 - $5,399	174 Added 17.61%	1,162 $35,000
Q3 2023 Oct 31, 2023	BUY	$26.2 - $36.08 $13,676 - $18,833	522 Added 112.02%	988 $26,000
Q2 2023 Jul 25, 2023	BUY	$25.16 - $41.38 $8,202 - $13,489	326 Added 232.86%	466 $16,000
Q1 2023 Apr 24, 2023	SELL	$23.68 - $38.51 $4,807 - $7,817	-203 Reduced 59.18%	140 $3,000
Q4 2022 Jan 25, 2023	SELL	$28.0 - $40.56 $2,100 - $3,042	-75 Reduced 17.94%	343 $0
Q3 2022 Oct 25, 2022	SELL	$29.63 - $48.31 $4,000 - $6,521	-135 Reduced 24.41%	418 $14,000
Q2 2022 Aug 04, 2022	BUY	$27.79 - $50.61 $9,393 - $17,106	338 Added 157.21%	553 $19,000
Q1 2022 Apr 19, 2022	SELL	$39.62 - $69.97 $8,795 - $15,533	-222 Reduced 50.8%	215 $10,000
Q4 2021 Feb 01, 2022	BUY	$58.09 - $82.51 $7,609 - $10,808	131 Added 42.81%	437 $29,000
Q3 2021 Oct 15, 2021	BUY	$58.38 - $84.96 $7,939 - $11,554	136 Added 80.0%	306 $19,000
Q2 2021 Aug 06, 2021	BUY	$62.15 - $90.32 $2,486 - $3,612	40 Added 30.77%	170 $14,000
Q1 2021 May 07, 2021	SELL	$61.35 - $90.47 $306 - $452	-5 Reduced 3.7%	130 $9,000
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $4,820 - $9,390	110 Added 440.0%	135 $10,000
Q3 2020 Nov 09, 2020	BUY	$33.21 - $51.27 $830 - $1,281	25 New	25 $1,000

Others Institutions Holding ARWR

# of Institutions

302

Shares Held

95.7M

Call Options Held

523K

Put Options Held

493K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.4B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Arrowhead Pharmaceuticals, Inc. Transaction History